Healthtech Investors & VC Firms in China

223 firms in this list, with a median first check of $1.4M. 31 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
6 6 Dimensions Capital CWFHLWNL17 people	88🔒	Grand Cayman	US	Seed–Late Stage	—	+ Add to CRM
PR Princeville Capital JKJRTMUC15 people	88🔒	San Francisco	US	Series A–Late Stage	—	+ Add to CRM
HB HBM Partners CLDDDUFD6 people	88🔒	Zug	CH	Pre-Seed–Late Stage	$5M – $50M	+ Add to CRM
DO DoubleRock NDSR2 people	88🔒	San Francisco	US	Seed–Series A	$2M – $15M	+ Add to CRM
VE Vertex Ventures HC CBLHYLJS4 people	88🔒	Singapore	SG	Seed–Growth	$500K – $10M	+ Add to CRM
AD AddVentures by SCG SPCLPJRM6 people	88🔒	Bangkok	TH	Seed–Late Stage	$1.5M – $66M	+ Add to CRM
TR Transcend Capital Partners GPJNWLJ6 people	88🔒	Hong Kong	HK	Pre-Seed–Series B	$2.5M – $5M	+ Add to CRM
SK Skywood Capital AWRWTZ3 people	88🔒	Silicon Valley	US	Seed–Growth	—	+ Add to CRM
VI Vision Creator	88🔒	Seoul	KR	Pre-Seed–Late Stage	—	+ Add to CRM
ED EDB Investments CKCLCGJO11 people	88🔒	Singapore	SG	Seed–Late Stage	$12M – $400M	+ Add to CRM
AL Alibaba Entrepreneurs Fund ALCC2 people	88🔒	Hong Kong	HK	Seed–Late Stage	$1.2M – $150M	+ Add to CRM
IN Innolinks Ventures HLTL2 people	88🔒	Palo Alto	US	Pre-Seed–Series A	—	+ Add to CRM
BO Boehringer Ingelheim Venture Fund JGAKDHDH7 people	88🔒	Ingelheim am Rhein	DE	Seed–Growth	$16.2M	+ Add to CRM
DS dsm-firmenich Venturing AKADIBSH9 people	88🔒	Maastricht	NL	Pre-Seed–Late Stage	$108K – $5.4M	+ Add to CRM
FR French Partners ÉLNMEL3 people	88🔒	Paris	FR	Seed–Growth	$1.1M – $5.4M	+ Add to CRM
TA Taihill Venture RABYT(FA6 people · Follows rounds	88🔒	Cambridge	US	Pre-Seed–Series A	—	+ Add to CRM
CA Cathay Health MCEDJHMV5 people	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
IN INP Capital JGNBJCSX6 people	88🔒	Vancouver	CA	Seed–Late Stage	—	+ Add to CRM
RO Rockley Group ARRRZX3 people	88🔒	Oxford	GB	Growth	—	+ Add to CRM
MA Majuven LHLTLYHK4 people	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
SY Syno Capital, LLC JXJRDXJW4 people	88🔒	New York	US	Series A	—	+ Add to CRM
SW Swedfund International AB	88🔒	Stockholm	SE	Series A–Growth	$3M – $10M	+ Add to CRM
FE Feast Ventures NS1 person	88🔒	Munich	DE	Pre-Seed–Seed	$165K – $550K	+ Add to CRM
FI Finnish Fund for Industrial Cooperation Ltd. (FINNFUND) OS1 person	88🔒	Helsinki	FI	Seed–Growth	$2.7M – $135M	+ Add to CRM

6 Dimensions Capital

Grand CaymanSeed–Late Stage

CWFHLWNL17 people

Princeville Capital

San FranciscoSeries A–Late Stage

JKJRTMUC15 people

HBM Partners

ZugPre-Seed–Late Stage$5M – $50M

CLDDDUFD6 people

DoubleRock

San FranciscoSeed–Series A$2M – $15M

NDSR2 people

Vertex Ventures HC

SingaporeSeed–Growth$500K – $10M

CBLHYLJS4 people

AddVentures by SCG

BangkokSeed–Late Stage$1.5M – $66M

SPCLPJRM6 people

Transcend Capital Partners

Hong KongPre-Seed–Series B$2.5M – $5M

GPJNWLJ6 people

Skywood Capital

Silicon ValleySeed–Growth

AWRWTZ3 people

Vision Creator

SeoulPre-Seed–Late Stage

EDB Investments

SingaporeSeed–Late Stage$12M – $400M

CKCLCGJO11 people

Alibaba Entrepreneurs Fund

Hong KongSeed–Late Stage$1.2M – $150M

ALCC2 people

Innolinks Ventures

Palo AltoPre-Seed–Series A

HLTL2 people

Boehringer Ingelheim Venture Fund

Ingelheim am RheinSeed–Growth$16.2M

JGAKDHDH7 people

dsm-firmenich Venturing

MaastrichtPre-Seed–Late Stage$108K – $5.4M

AKADIBSH9 people

French Partners

ParisSeed–Growth$1.1M – $5.4M

ÉLNMEL3 people

Taihill Venture

CambridgePre-Seed–Series A

RABYT(FA6 people

Cathay Health

San FranciscoSeed–Late Stage

MCEDJHMV5 people

INP Capital

VancouverSeed–Late Stage

JGNBJCSX6 people

Rockley Group

OxfordGrowth

ARRRZX3 people

Majuven

SingaporeSeed–Late Stage

LHLTLYHK4 people

Syno Capital, LLC

New YorkSeries A

JXJRDXJW4 people

Swedfund International AB

StockholmSeries A–Growth$3M – $10M

Feast Ventures

MunichPre-Seed–Seed$165K – $550K

NS1 person

Finnish Fund for Industrial Cooperation Ltd. (FINNFUND)

HelsinkiSeed–Growth$2.7M – $135M

OS1 person

Data sourced from public filings and firms' own websites — see our methodology.